These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9747643

  • 1. Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus.
    Pelikánová T, Pinsker P, Smrcková I, Stribrná L, Dryáková M.
    J Diabetes Complications; 1998; 12(5):264-72. PubMed ID: 9747643
    [Abstract] [Full Text] [Related]

  • 2. [Renal hemodynamics and its regulation in recently diagnosed type 1 diabetes mellitus (insulin-dependent diabetes mellitus). The effect of hyperglycemia].
    Pelikánová T, Pinsker P, Smrcková I, Stríbrná L, Dryáková M.
    Cas Lek Cesk; 1997 Sep 10; 136(17):533-8. PubMed ID: 9441014
    [Abstract] [Full Text] [Related]

  • 3. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control.
    Mayfield RK, Margolius HS, Levine JH, Wohltmann HJ, Loadholt CB, Colwell JA.
    J Clin Endocrinol Metab; 1984 Aug 10; 59(2):278-86. PubMed ID: 6564131
    [Abstract] [Full Text] [Related]

  • 4. Effects of insulin and lipid emulsion on renal haemodynamics and renal sodium handling in IDDM patients.
    Pelikánová T, Smrcková I, Krízová J, Stríbrná J, Lánská V.
    Diabetologia; 1996 Sep 10; 39(9):1074-82. PubMed ID: 8877292
    [Abstract] [Full Text] [Related]

  • 5. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K, Yasujima M, Chiba S, Sato M, Irokawa N, Imai Y, Yoshinaga K.
    Adv Exp Med Biol; 1979 Sep 10; 120B():487-501. PubMed ID: 517244
    [Abstract] [Full Text] [Related]

  • 6. Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins.
    Esmatjes E, Fernandez MR, Halperin I, Camps J, Gaya J, Arroyo V, Rivera F, Figuerola D.
    J Clin Endocrinol Metab; 1985 Jun 10; 60(6):1231-6. PubMed ID: 3858281
    [Abstract] [Full Text] [Related]

  • 7. Effect of acute hyperglycaemia on sodium handling and excretion of nitric oxide metabolites, bradykinin, and cGMP in Type 1 diabetes mellitus.
    Simková R, Kazdová L, Karasová L, Simek S, Pelikánová T.
    Diabet Med; 2004 Sep 10; 21(9):968-75. PubMed ID: 15317600
    [Abstract] [Full Text] [Related]

  • 8. [Regulation of natriuresis in diabetic nephropathy].
    Późniak J.
    Ann Acad Med Stetin; 2000 Sep 10; 46():241-52. PubMed ID: 11712308
    [Abstract] [Full Text] [Related]

  • 9. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M, Abe K, Irokawa N, Ito T, Yasujima M, Sakurai Y, Chiba S, Saito K, Ritz K, Kusaka T, Miyazaki S, Yoshinaga K.
    Tohoku J Exp Med; 1978 Mar 10; 124(3):197-203. PubMed ID: 635897
    [Abstract] [Full Text] [Related]

  • 10. Plasma renin activity and urinary kallikrein excretion in response to intravenous furosemide in diabetic patients.
    Lall SB, Kunchaparty S, Siddiqui HH, Bajaj JS.
    Acta Diabetol Lat; 1990 Mar 10; 27(4):337-42. PubMed ID: 2087934
    [Abstract] [Full Text] [Related]

  • 11. The two mechanisms involved in the control of urinary kallikrein excretion.
    Mills IH, Newport PA.
    Adv Exp Med Biol; 1986 Mar 10; 198 Pt B():233-41. PubMed ID: 3643725
    [Abstract] [Full Text] [Related]

  • 12. Urinary kallikrein excretion in type 1 (insulin-dependent) diabetes mellitus.
    Manto A, Cotroneo P, Porcelli G, D'Errico G, Marra G, Magnani P, Tilli P, Greco AV, Ghirlanda G.
    Diabetologia; 1993 May 10; 36(5):423-7. PubMed ID: 8314446
    [Abstract] [Full Text] [Related]

  • 13. Interactions of diuretics with the renal kallikrein-kinin and prostaglandin systems.
    Overlack A, Stumpe KO, Müller HM, Kolloch R, Higuchi M.
    Klin Wochenschr; 1982 Oct 01; 60(19):1223-8. PubMed ID: 6183482
    [Abstract] [Full Text] [Related]

  • 14. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S, Kher V, Scicli AG, Beierwaltes WH, Carretero OA.
    Hypertension; 1983 Oct 01; 5(6):893-9. PubMed ID: 6197374
    [Abstract] [Full Text] [Related]

  • 15. Relationship of urinary kallikrein excretion to urinary potassium excretion during furosemide administration with and without amiloride.
    Obika LF.
    Arch Int Physiol Biochim; 1987 Mar 01; 95(1):13-8. PubMed ID: 2441670
    [Abstract] [Full Text] [Related]

  • 16. Relationship between kallikrein and PRA after intravenous furosemide.
    Cinotti GA, Stirati G, Taggi F, Ronci R, Simonetti BM, Pierucci A.
    J Endocrinol Invest; 1979 Mar 01; 2(2):147-50. PubMed ID: 489923
    [Abstract] [Full Text] [Related]

  • 17. Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function.
    Harvey JN, Edmundson AW, Jaffa AA, Martin LL, Mayfield RK.
    Diabetologia; 1992 Sep 01; 35(9):857-62. PubMed ID: 1397781
    [Abstract] [Full Text] [Related]

  • 18. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP, Oyama TT, Thompson MM, Anderson S.
    Diabetes; 1997 Jan 01; 46(1):107-12. PubMed ID: 8971089
    [Abstract] [Full Text] [Related]

  • 19. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H, Fleckenstein P, Geiger R, Fink E, Sinterhauf K, Philipp T, Distler A, Wolff HP.
    Clin Exp Hypertens (1978); 1980 Jan 01; 2(3-4):693-708. PubMed ID: 7000466
    [Abstract] [Full Text] [Related]

  • 20. Hypertension in adult onset diabetes mellitus: abnormal renal hemodynamics and endogenous vasoregulatory factors.
    Olshan AR, O'Connor DT, Cohen IM, Stone RA.
    Am J Kidney Dis; 1982 Sep 01; 2(2):271-80. PubMed ID: 6751073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.